MLchartDataset catalogue

Adcetris

Term · Oncology and biomedicine · MLC-T-ONC-000229

A drug used alone or with other drugs to treat adults with certain types of classic Hodgkin lymphoma, cutaneous or systemic anaplastic large cell lymphoma, large B-cell lymphoma, mycosis fungoides, or peripheral T-cell lymphoma, and with other drugs to treat children aged 2 years and older with certain types of classic Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Adcetris contains a monoclonal antibody that binds to a protein called CD30, which is found on some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Adcetris is a type of antibody-drug conjugate. Also called brentuximab vedotin and SGN-35.

Table 1. Record
IdentifierMLC-T-ONC-000229
FieldOncology and biomedicine
Synonymsbrentuximab vedotin; SGN-35
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000229",
  "term": "Adcetris",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of classic Hodgkin lymphoma, cutaneous or systemic anaplastic large cell lymphoma, large B-cell lymphoma, mycosis fungoides, or peripheral T-cell lymphoma, and with other drugs to treat children aged 2 years and older with certain types of classic Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Adcetris contains a monoclonal antibody that binds to a protein called CD30, which is found on some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Adcetris is a type of antibody-drug conjugate. Also called brentuximab vedotin and SGN-35.",
  "synonyms": [
    "brentuximab vedotin",
    "SGN-35"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/adcetris/"
}

Record 373 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.